Curate

What Curate does

Curate Health (TheCurateGroup Limited, founded 2022) is a UK-regulated direct-to-consumer digital pharmacy selling clinician-prescribed medications across three clinical categories: weight management (using GLP-1 products Mounjaro, Wegovy Pen, and the newly launched oral Wegovy Pill), men's sexual health (Sildenafil and Tadalafil), and male pattern hair loss (Finasteride). All prescribing is performed by named UK-registered clinicians — six prescribing pharmacists led by a Superintendent Pharmacist at Marlow (GPhC registration 9012920) — with clinical services provided through a third-party partner, Chiltern Private Limited, regulated by the CQC; the company explicitly does not use software to prescribe. A proprietary 'Curated Nutrition' house brand (Nourish protein shakes, Renew collagen supplements) provides a non-prescription cross-sell line, and the platform offers both pay-as-you-go and 3/6/9/12-month subscription billing, with a 48-hour average clinician review turnaround, a £15 non-refundable clinical administrative fee per order, and flat £5 next-day delivery via DPD and Royal Mail across the UK including Northern Ireland.

The underlying technology is a conventional online consultation platform consisting of a confidential patient assessment intake, a clinician review workflow, and a prescription management system integrated with registered pharmacy operations; the company markets 'data-led' assessments that capture symptoms, history, goals, and health markers to guide clinician decision-making rather than to automate it. Distribution is fully direct-to-consumer through curatehealth.co.uk and a separate consultation subdomain, with no pharmacy aggregator or B2B channel referenced. The go-to-market motion is digital-first, with SEO-optimised content, BMI/eligibility self-check tools, a self-serve consultation funnel, post-sale email marketing, and social media competitions forming the primary acquisition channels.

The business model is consumption-based, with no disclosed subscription lock-in (pay-as-you-go is available alongside subscription) and no disclosed revenue figures; the company has raised a single disclosed funding round of approximately £750k in November 2022 and operates with a headcount of 1-10, making it a sub-scale, bootstrapped-leaning operator in a category where UK GLP-1 telehealth demand has been accelerating sharply.

Name

Curate

Legal name

TheCurateGroup Limited

Website

https://curatehealth.co.uk

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Short description

Curate Health is a UK-regulated direct-to-consumer digital pharmacy (GPhC-registered, CQC-regulated prescribing) selling clinician-prescribed weight loss (Mounjaro, Wegovy), erectile dysfunction (Sildenafil, Tadalafil), and hair loss (Finasteride) treatments to individual UK consumers via online consultations.

Ownership category

akta.pro rank

Product category

Digital Pharmacy / Telehealth

NAICS

Pharmacies and Drug Retailers (45611)

SIC

Retail-Drug Stores And Proprietary Stores (5912)

akta.pro primary industry

Prescription-Based Digital Clinics (Condition-Specific Rx Programs) (HLALAAAD)

akta.pro secondary industries

DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription) (HLALAIAA), Pharmacy & Health Essentials Delivery (CRAFAFAI)

Keywords

• Online pharmacy services
• Digital healthcare platform
• Weight loss treatments
• Men's health treatments
• Telehealth prescriptions

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medication sales: Direct sale of prescription medications including GLP-1 treatments (Mounjaro, Wegovy), erectile dysfunction treatments (Sildenafil, Tadalafil), and Finasteride for hair loss. One-off purchases or subscription plans (3, 6, 9, or 12 months) available.
2. Curated Nutrition supplements: House range of daily nutrition products including Nourish protein shakes and Renew collagen supplements. No prescription required. Coming soon products in development.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Curate Health is a UK-regulated digital pharmacy that delivers clinician-prescribed weight-loss (Mounjaro, Wegovy Pen, Wegovy Pill), sexual-health (Sildenafil, Tadalafil), and hair-loss (Finasteride) treatments, alongside daily nutrition supplements (Nourish, Renew). Patients complete a confidential online consultation that is reviewed by named UK-registered prescribing pharmacists, with prescribed medication dispensed from a GPhC-registered pharmacy and delivered in discreet packaging. Care is offered on a pay-as-you-go or multi-month subscription basis with scheduled 4-weekly clinical reviews and the option to pause or stop at any time.

Product overview

Curate Health is a UK regulated digital pharmacy offering personalised healthcare across four clinical pathways: weight loss, hair loss, sexual health, and curated nutrition. The core offering consists of clinician-prescribed medications delivered through an online consultation platform with ongoing clinical oversight. Weight loss treatments include Mounjaro (tirzepatide, a dual GLP-1/GIP agonist weekly injection), Wegovy Pen (semaglutide weekly injection), and the newly launched Wegovy Pill (oral semaglutide daily tablet). Sexual health treatments include Sildenafil and Tadalafil (PDE5 inhibitors for erectile dysfunction). Hair loss treatment consists of Finasteride (DHT inhibitor). Supporting products include Nourish (protein and vitamin meal replacement shake) and Renew (collagen supplement). All treatments include 4-weekly clinician reviews, with prescribing provided by GPhC-registered pharmacists and CQC-regulated services.

Differentiator

Problem solved

Functional benefit

Products and services

• Mounjaro Weekly subcutaneous tirzepatide injection for weight management. Tirzepatide mimics both GLP-1 and GIP hormones (dual agonist). Available in doses 2.5mg to 15mg with gradual titration and monthly check-ins under clinician review. Clinically demonstrated up to 21% average body-weight reduction over 72 weeks in the SURMOUNT-1 trial. Dispensed in the UK only with prescription.
• Wegovy Pen Weekly subcutaneous semaglutide injection for weight management. Semaglutide mimics the appetite-regulating hormone GLP-1. Available in doses 0.25mg to 7.2mg with gradual titration, monthly clinician check-ins, and discreet home delivery. Clinically demonstrated up to 20.7% average body-weight reduction with the 2.4mg dose over 68 weeks in the STEP 1 trial.
• Wegovy Pill Once-daily oral semaglutide tablet for weight management. Contains the same active ingredient as Wegovy injection but in oral form — the first oral GLP-1 MHRA-approved for obesity in the UK. Doses of 1.5mg, 4mg, 9mg, and 25mg; the 1.5mg and 4mg doses are available as one-time purchases. Clinically demonstrated up to 16.6% average body-weight reduction with the 25mg dose over 64 weeks in the OASIS 4 trial.
• Sildenafil Prescription PDE5 inhibitor for erectile dysfunction. Increases blood flow to the penis during sexual stimulation. Available as 25mg, 50mg, and 100mg tablets, taken as needed approximately 30–60 minutes before sex, with 1-, 2-, and 3-month supply options priced by dose strength.
• Tadalafil Prescription PDE5 inhibitor for erectile dysfunction. Available as a 5mg daily low-dose tablet for spontaneous use or as-needed 10mg and 20mg tablets. Effects can last up to 36 hours (the 'weekend pill'). Priced by dose strength and duration (1-, 2-, or 3-month supply).
• Finasteride Prescription 5-alpha reductase inhibitor for androgenetic alopecia (male pattern hair loss). Reduces DHT levels to slow hair loss and promote regrowth. Taken as a 1mg daily tablet, reviewed by a UK-registered clinician. Approximately 85% of eligible men stop losing hair or see regrowth after 4 months; 66% experience visible hair regrowth after 12 months. From £12.99/month subject to clinical consultation.
• Nourish Clinician-curated daily nutrition shake formulated to complement GLP-1 weight-loss treatment. High in protein (19-20g per serving) and fibre with 25 essential vitamins and minerals, sold as a meal replacement for weight control in chocolate and strawberry flavours. Available without a prescription.
• Renew Daily collagen and hyaluronic acid supplement containing 10g collagen peptides and 125mg hyaluronic acid for skin, hair, and joint support. Designed to complement GLP-1 weight-loss treatment. Available without a prescription.

Quantifiable outcome

• Up to 21% average body-weight reduction with tirzepatide (Mounjaro) over 72 weeks in SURMOUNT-1 trial
• +4 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Four partnerships are on record, tiered core and supporting.

• Chiltern Private LimitedcoreStrategic or Co-development PartnerIndependent third-party clinical provider regulated by the Care Quality Commission (CQC location ID 1-23688049165). Provides prescribing services including GMC-registered doctors and GPhC-registered independent pharmacist prescribers. Consultation information and health data securely shared for clinical assessment, prescribing, and ongoing medical management. Acts as independent data controller for prescribing services.
• Eli Lilly (Mounjaro manufacturer)coreOthersManufacturer of Mounjaro (tirzepatide), a prescription GLP-1 medication for weight loss. Curate dispenses genuine, regulated medication. Patient information leaflets and step-by-step guidance referenced from Eli Lilly.
• Novo Nordisk (Wegovy manufacturer)coreOthersManufacturer of Wegovy (semaglutide), a prescription GLP-1 medication for weight loss. Curate dispenses genuine, regulated medication. Step-by-step injection guidance referenced from Novo Nordisk.
• DPD and Royal MailsupportingChannel Partner/ Reseller/ DistributorCourier partners for next-day delivery of medications. DPD and Royal Mail provide tracked shipping with delivery notifications and flexible delivery options. Orders shipped in temperature-regulating packaging with ice packs.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Numan: UK-regulated DTC telehealth platform offering prescription treatments for men's health (ED, hair loss) and weight management — directly overlapping Curate's three core categories with a similar online consultation and subscription model.
• Zava: UK online clinic providing private prescription consultations across weight loss, ED, hair loss and other conditions. Operates a comparable DTC, GPhC-regulated, online-assessment model serving UK patients.
• Manual: UK men's health and wellness DTC platform offering prescription hair loss and ED treatments plus supplements — overlapping Curate's ED and hair loss lines with a similar pay-as-you-go and subscription offering.
• Juniper: UK DTC telehealth focusing on women's weight loss, including access to GLP-1 medications via partner clinicians. Direct overlap with Curate's 'Curated for Her' weight loss offering.
• Voy: UK weight-loss telehealth that dispenses GLP-1 medications (Mounjaro, Wegovy) through online clinician review. Closest direct competitor to Curate's GLP-1 weight-loss pipeline.
• MedExpress: UK online clinic offering confidential consultations and prescription dispensing for weight loss, ED and hair loss — directly overlapping Curate's product mix and DTC consultation model.
• The Independent Pharmacy: UK GPhC-registered online pharmacy dispensing private prescriptions across weight loss, ED, hair loss and other conditions. A comparable regulated distance-selling pharmacy with clinician-led prescribing.

Broad incumbents

• Pharmacy2U: Largest UK distance-selling pharmacy, dispensing NHS and private prescriptions online. Same GPhC-regulated distance-selling pharmacy model as Curate but at much larger scale across general medicine.
• Hims & Hers Health: Large US-listed DTC telehealth platform for weight loss, ED, hair loss and other conditions. Comparable business model and product set; not currently a UK competitor at scale but is the category-defining benchmark.

Regional players

• Simple Online Pharmacy: Scotland-based GPhC-registered online pharmacy dispensing weight-loss injections and other prescriptions via online consultation. Comparable regulated distance-selling pharmacy model with overlapping weight-loss focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/curatehealth
• LinkedInlinkedin.com/company/curate-health

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Curate